Drug Type Other diagnostic agent |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Selecxine, Inc. Co Ltd.Startup |
Active Organization Selecxine, Inc. Co Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diagnostic agents | Preclinical | KR | Selecxine, Inc. Co Ltd.Startup | 04 Oct 2024 |
Neoplasms | Preclinical | KR | Selecxine, Inc. Co Ltd.Startup | 04 Oct 2024 |